Heart failure and mortality risk in patients undergoing high-dose chemotherapy with autologous stem cell transplant for breast cancer after radiotherapy.


135 Background: High-dose chemotherapy (HDCT) with autologous hematopoietic stem cell transplant (HSCT) has been used as part of the treatment of metastatic breast cancer. However, the evidence behind this approach continues to be controversial. We hypothesize that previous radiation therapy (RT) may increase the risk of cardiomyopathy and mortality in… (More)
DOI: 10.1200/jco.2013.31.26_suppl.135